Review
Accepted on 17 Feb 2025
Oncocytic pituicytoma in a patient with Cushing's disease: a case report and narrative literature review
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1487120
Type at least 3 characters
448 articles
Articles
Original Research
Published on 07 Feb 2025
Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1534891
- 272 views
Mini Review
Accepted on 06 Feb 2025
A Case-Based Review of Adult-Onset Craniopharyngioma
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1527161
Original Research
Accepted on 05 Feb 2025
Biochemical Remission, Diagnostic Delays, and Comorbidities of Acromegaly in China: A Large Single-Centre Retrospective Study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1526625
Original Research
Published on 03 Feb 2025
Patient perspectives on acromegaly disease burden: insights from a community meeting
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1516131
- 230 views
Original Research
Accepted on 31 Jan 2025
Outcomes of Transsphenoidal Surgery for Pituitary Adenomas in Spain (TESSPAIN): A
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1529418
Original Research
Published on 31 Jan 2025
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1516899
- 276 views
Correction
Published on 28 Jan 2025
Corrigendum: A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1546763
- 278 views
Original Research
Published on 15 Jan 2025
Prevalence and predictive factors of testosterone-induced erythrocytosis: a retrospective single center study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1496906
- 575 views
Original Research
Published on 23 Dec 2024
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1511155
- 560 views
Original Research
Published on 17 Dec 2024
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1472680
- 604 views
Mini Review
Published on 16 Dec 2024
Everolimus in pituitary tumor: a review of preclinical and clinical evidence
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1456922
- 787 views
Original Research
Published on 13 Dec 2024
A clinical practical model for preoperative prediction of visual outcome for pituitary adenoma patients in a retrospective and prospective study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1479442
- 679 views
Review
Published on 13 Dec 2024
Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1455465
- 1,041 views
Original Research
Published on 06 Dec 2024
Comparative analysis of clinical characteristics of symptomatic pituitary adenomas in elderly patients: a consecutive series of 114 patients
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1385813
- 453 views
Original Research
Published on 28 Nov 2024
Elucidating the causal links between plasma and cerebrospinal fluid metabolites and pituitary tumors: a Mendelian randomization analysis
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1460278
- 1,017 views